Země: Velká Británie
Jazyk: angličtina
Zdroj: MHRA (Medicines & Healthcare Products Regulatory Agency)
Venlafaxine hydrochloride
Ethypharm UK Ltd
N06AX16
Venlafaxine hydrochloride
37.5mg
Modified-release tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04030400; GTIN: 5060078671569
Page 1 of 2 PACKAGE LEAFLET: INFORMATION FOR THE USER AXYVEN XL 37.5MG PROLONGED-RELEASE TABLETS (venlafaxine hydrochloride) Your medicine is available using the name Axyven XL 37.5mg prolonged-release tablets but will be referred to as Axyven XL throughout this leaflet. Other strengths 75mg, 150mg and 225mg are also available. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. ▪ Keep this leaflet. You may need to read it again. ▪ If you have any further questions, please ask your doctor or pharmacist. ▪ This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. ▪ If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Axyven XL is and what it is used for 2. What you need to know before you take Axyven XL 3. How to take Axyven XL 4. Possible side effects 5. How to store Axyven XL 6. Contents of the pack and other information 1. WHAT AXYVEN XL IS AND WHAT IT IS USED FOR Axyven XL contains the active substance venlafaxine. Axyven XL is an antidepressant that belongs to a group of medicines called serotonin and norepinephrine reuptake inhibitors (SNRIs). This group of medicines is used to treat depression and other conditions such as anxiety disorders. It is thought that people who are depressed and/or anxious have lower levels of serotonin and noradrenaline in the brain. It is not fully understood how antidepressants work, but they may help by increasing the levels of serotonin and noradrenaline in the brain. Axyven XL is a treatment for adults with depression. Axyven XL is also a treatment for adults with the following anxiety disorders: generalised anxiety disorder, social anxiety disorder (fear or avoidance of social situations) and panic disorder (panic attacks). Treating depression or anxiety disorders properly is import Přečtěte si celý dokument
OBJECT 1 VENLALIC XL PROLONGED RELEASE TABLETS Summary of Product Characteristics Updated 05-Jun-2018 | Ethypharm UK Ltd 1. Name of the medicinal product Venlalic XL 37.5 mg prolonged-release tablets Venlalic XL 75 mg prolonged-release tablets Venlalic XL 150 mg prolonged-release tablets Venlalic XL 225 mg prolonged-release tablets 2. Qualitative and quantitative composition Venlalic XL 37.5 mg prolonged-release tablets Each prolonged-release tablet contains 37.5 mg venlafaxine (as hydrochloride). Venlalic XL 75 mg prolonged-release tablets Each prolonged-release tablet contains 75 mg venlafaxine (as hydrochloride). Venlalic XL 150 mg prolonged-release tablets Each prolonged-release tablet contains 150 mg venlafaxine (as hydrochloride). Venlalic XL 225 mg prolonged-release tablets Each prolonged-release tablet contains 225 mg venlafaxine (as hydrochloride). Excipient with known effect: lactose 3.0 / 3.4 / 5.7 / 6.5 mg For the full list of excipients, see section 6.1. 3. Pharmaceutical form Prolonged-release tablet 37.5 mg prolonged-release tablets: 7 mm round, biconvex, white tablets. 75 mg prolonged-release tablets: 7.5 mm round, biconvex, white tablets. 150 mg prolonged-release tablets: 9.5 mm round, biconvex, white tablets. 225 mg prolonged-release tablets: 11 mm round, biconvex, white tablets 4. Clinical particulars 4.1 Therapeutic indications Treatment of major depressive episodes. For prevention of recurrence of major depressive episodes. Treatment of generalised anxiety disorder. Treatment of social anxiety disorder. Treatment of panic disorder, with or without agoraphobia. 4.2 Posology and method of administration Posology _Major depressive episodes_ The recommended starting dose for prolonged-release venlafaxine is 75 mg given once daily. Patients not responding to the initial 75 mg/day dose may benefit from dose increases up to a maximum dose of 375 mg/day. Dosage increases can be made at intervals of 2 weeks or more. If clinically warranted due to symptom severity, dose increases can be made at more fr Přečtěte si celý dokument